107 patents
Page 4 of 6
Utility
Monoclonal antibodies and methods of use
3 May 22
This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog.
Sarah Rue, Brendan Eckelman, Quinn L. Deveraux, Marc Nasoff
Filed: 24 Aug 17
Utility
Probiotic Compositions Comprising Lactobacillus Reuteri Strains and Methods of Use
28 Apr 22
The present invention relates to probiotic compositions and methods for increasing animal health.
Arvind KUMAR, Dharanesh Mahimapura GANGAIAH
Filed: 4 Feb 20
Utility
a Genetically Modified Lactobacillus and Uses Thereof
28 Apr 22
The present invention relates to efficient delivery of anti-infective activity, immunomodulatory factors, or growth-promoting biomolecules directly to the digestive tract of an animal via a live delivery platform.
Dharanesh Mahimapura GANGAIAH, Arvind KUMAR, Lin LIU, Shrinivasrao Peerajirao MANE, Valerie Elyse RYAN
Filed: 4 Feb 20
Utility
Probiotic Compositions Comprising Lactobacillus Reuteri Strains and Methods of Use
24 Mar 22
The present invention relates to probiotic compositions and methods for increasing animal health.
Arvind KUMAR, Dharanesh Mahimapura GANGAIAH
Filed: 15 Oct 21
Utility
Preparation of Live Vaccines
24 Mar 22
Described is a method for the generation of a live vaccine containing stable bacteria carrying at least three attenuating mutations and a vaccine containing bacteria obtained by said method.
Klaus LINDE, Anke GROSSE-HERRENTHEY
Filed: 5 Aug 20
Utility
Formulations for bovine granulocyte colony stimulating factor and variants thereof
15 Mar 22
This invention provides stable aqueous formulations comprising a bG-CSF polypeptide or a variant thereof, a buffer substance, and an excipient, wherein said formulation is substantially free of polyoxyethylene (20) sorbitan monolaurate.
Alan Voskamp Klotz, Catherine Ngan Kha, Juan Davagnino
Filed: 22 Sep 11
Utility
Bicyclic Derivatives
3 Mar 22
Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
Filed: 13 Dec 19
Utility
Bicyclic Derivatives
3 Mar 22
Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
Filed: 13 Dec 19
Utility
Animal intranasal administration device, systems, and associated methods
1 Mar 22
A veterinary subject intranasal administration device includes a first support member portion including a septum interface portion sized for insertion into a nasal passage of the veterinary subject; an actuation mechanism connected to the first support member portion; and a fluid conduit having a distal end opposite a supported end, the distal end sized for insertion into the nasal passage of the veterinary subject, the fluid conduit being flexible and configured to receive fluid from a fluid source and discharge the fluid through the distal end into the nasal passage, the distal end of the fluid conduit being unsupported and movable relative to the septum interface portion.
Amy L. Marr, Jane Granville Owens, Jeffrey Kyle Hill, Casey J. Strange, Randall Lee Waln, Christopher C. Miller, Gilly Regev-Shoshani, Alex Stenzler, Steve Han
Filed: 19 Jul 17
Utility
Quinoline derivatives for treating infections with helminths
22 Feb 22
Nils Griebenow, Wei Zhuang, Daniel Kulke, Claudia Böhm, Hans-Georg Schwarz, Walter Hübsch, Thomas Ilg
Filed: 30 Jul 18
Utility
Potentiation of Helminth Treatment
13 Jan 22
The present invention provides a method of treating liver fluke infections in a mammal in need of such treatment comprising administering an effective amount of diamphenethide in combination with an effective amount of clorsulon.
Sarah George, Peter Rolfe, Chouaib Tahtaoui
Filed: 30 Sep 19
Utility
Novel Compounds for Controlling Arthropods
13 Jan 22
The present invention relates to novel halogen-substituted compounds, to processes for their preparation and to their use for controlling animal pests, in particular arthropods and especially insects and arachnids.
Joachim TELSER, Ursula KRENZ, Kirsten BOERNGEN, Andreas TURBERG, Klein SOFIA, Franziska SCHMIDT
Filed: 27 Jun 19
Utility
Combinations of Lysobactin and Aminoglycosides Against Diseases Caused by Gram-positive and Gram-negative Bacteria In Non-human Animals
6 Jan 22
The present invention relates to the combination of lysobactin with an aminoglycoside antibiotic for use in the treatment of diseases caused by Gram-positive and Gram-negative bacteria in non-human animals.
Guido SCHIFFER, Stefan FALKER, Gert DAUBE, Wolfgang WIEHL, Johannes KOEBBERLING
Filed: 3 Sep 21
Utility
New Anthelmintic Compounds
9 Dec 21
Nils GRIEBENOW, Walter HUEBSCH, Hans-Georg SCHWARZ, Wei ZHUANG, Bernd ALIG, Adeline KEHLER, Daniel KULKE, Iring HEISLER, Thomas ILG
Filed: 23 Oct 19
Utility
Bovine Respiratory Disease Vaccine
4 Nov 21
The present invention relates to vaccines for treating bovine respiratory disease.
Lucas Huntimer, Thomas Halbur
Filed: 27 Apr 18
Utility
Tablets with improved acceptance and good storage stability
19 Oct 21
The present invention relates to tablets for animals, having improved acceptance and good storage stability.
Venkata-Rangarao Kanikanti, Hans-Juergen Hamann, Georg Schulte, Patrick Billian
Filed: 16 Dec 19
Utility
CorrectedMethods and Formulations for Reducing Bovine Emissions
30 Sep 21
The present disclosure provides methods and formulations for reducing ammonia and carbon dioxide emissions from a bovine using lubabegron, or a physiologically acceptable salt thereof.
Cory T. Herr, John Charles Kube, Jerold Scott Teeter
Filed: 3 Oct 16
Utility
Bicyclic pyrazole derivatives
28 Sep 21
Nils Griebenow, Wei Zhuang, Daniel Kulke, Adeline Köhler, Thomas Ilg, Claudia Welz, Hans-Georg Schwarz, Ulrich Görgens, Walter Hübsch, Johannes Köbberling
Filed: 23 Apr 18
Utility
Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals
3 Aug 21
The present application relates to the use of fused heteroaromatic pyrrolidones for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals and to the use thereof for production of medicaments for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially of atopic dermatitis and/or Flea Allergy Dermatitis, and especially in domestic animals, particularly in dogs.
Nils Griebenow, Maria De Lourdes Mottier, Gerald Beddies, Jörg Cramer, Ulf Bömer, Iring Heisler
Filed: 15 Oct 18
Utility
Formulation for the Use In the Simultaneous Treatment of Coccidial Infections and Iron Deficiencies
29 Jul 21
The present invention relates to a formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies containing a triazinone such as toltrazuril and a polynuclear iron(III) polysaccharide complex compound together with a specifically selected surfactant that has a hydrophilic-lipophilic-balance (HLB) value of ≥10.
Stefan Hofmann, Kirsten Borngen, Maya Vinzing
Filed: 29 May 19